CEBS: A comprehensive annotated database of toxicological data

Nucleic Acids Research

Volumn 45, Issue D1, 2017, Pages D964-D971

  Lea, Isabel A ^a   Gong, Hui ^a   Paleja, Anand ^a   Rashid, Asif ^a   Fostel, Jennifer ^b  

^a ASRC Federal Vistronix   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CARCINOGENICITY; CHEMICAL EFFECT IN BIOLOGICAL SYSTEM DATABASE; COMPUTER INTERFACE; DATA ANALYSIS; DATA PROCESSING; GENETIC DATABASE; INFORMATION PROCESSING; NONHUMAN; TOXICOLOGY; FACTUAL DATABASE; HUMAN; NUCLEIC ACID DATABASE; PROCEDURES; SEARCH ENGINE; TOXICOGENETICS; WEB BROWSER;

DATABASES, FACTUAL; DATABASES, NUCLEIC ACID; HUMANS; SEARCH ENGINE; TOXICOGENETICS; TOXICOLOGY; USER-COMPUTER INTERFACE; WEB BROWSER;

EID: 85016136657     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw1077     Document Type: Article

References (25)

1. Waters, M., Stasiewicz, S., Merrick, B.A., Tomer, K., Bushel, P., Paules, R., Stegman, N., Nehls, G., Yost, K.J., Johnson, C.H. et al. (2008) CEBS-Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data. Nucleic Acids Res., 36, D892-D900.
2. Waters, M., Boorman, G., Bushel, P., Cunningham, M., Irwin, R., Merrick, A., Olden, K., Paules, R., Selkirk, J., Stasiewicz, S. et al. (2003) Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. EHP Toxicogenomics, 111, 15-28.
3. Xirasagar, S., Gustafson, S.F., Huang, C.C., Pan, Q., Fostel, J., Boyer, P., Merrick, B.S., Tomer, K.B., Chan, D.D., Yost 3rd, K.J. et al. (2006) Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application., Bioinformatics 22, 874-882.
4. Fostel, J., Choi, D., Zwickl, C., Morrison, N., Rashid, A., Hasan, A., Bao, W., Richard, A., Tong, W., Bushel, P.R. et al. (2005) Chemical effects in biological systems-data dictionary (CEBS-DD): a compendium of terms for the capture and integration of biological study design description, conventional phenotypes, and 'omics data. Toxicol. Sci., 88, 585-601.
5. Davis, A.P., Grondin, C.J., Lennon-Hopkins, K., Saraceni-Richards, C., Sciaky, D., King, B.L., Wiegers, T.C. and Mattingly, C.J. (2015) The Comparative Toxicogenomics Database's 10th year anniversary: update 2015. Nucleic Acids Res., 43, D914-D920.
6. Members, S.I.B.S.I.o.B. (2016) The SIB Swiss Institute of Bioinformatics' resources: focus on curated databases. Nucleic Acids Res., 44, D27-D37.
7. Judson, R.S., Martin, M.T., Egeghy, P., Gangwal, S., Reif, D.M., Kothiya, P., Wolf, M., Cathey, T., Transue, T., Smith, D. et al. (2012). Aggregating data for computational toxicology applications: the U.S. Environmental Protection Agency (EPA) Aggregated Computational Toxicology Resource (ACToR) System. Int. J. Mol. Sci., 13, 1805-1831.
8. Kim, S., Thiessen, P.A., Bolton, E.E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B.A. et al. (2016). PubChem Substance and Compound databases. Nucleic Acids Res., 44, D1202-D1213.
9. Hastings, J., Owen, G., Dekker, A., Ennis, M., Kale, N., Muthukrishnan, V., Turner, S., Swainston, N., Mendes, P. and Steinbeck, C. (2016) ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res., 44, D1214-1219.
10. Igarashi, Y, Nakatsu, N., Yamashita, T., Ono, A., Ohno, Y, Urushidani, T. and Yamada, H. (2015) Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res., 43, D921-D927.
11. Kolesnikov, N., Hastings, E., Keays, M., Melnichuk, O., Tang, Y.A., Williams, E., Dylag, M., Kurbatova, N., Brandizi, M., Burdett, T. et al (2015) ArrayExpress update-simplifying data submissions. Nucleic Acids Res., 43, D1113-D1116.
12. Kinsner-Ovaskainen, A., Rzepka, R., Rudowski, R., Coecke, S., Cole, T. and Prieto, P. (2009) Acutoxbase, an innovative database for in vitro acute toxicity studies. Toxicol. In Vitro, 23, 476-485.
13. Ganter, B., Tugendreich, S., Pearson, C.I., Ayanoglu, E., Baumhueter, S., Bostian, K.A., Brady, L., Browne, L.J., Calvin, J.T., Day, G.J. et al. (2005) Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol., 119, 219-244.
14. Natsoulis, G, El Ghaoui, L., Lanckriet, GR., Tolley, A.M., Leroy, F., Dunlea, S., Eynon, B.P., Pearson, C.I., Tugendreich, S. and Jarnagin, K. (2005) Classifcation of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res., 15, 724-736.
15. Hsieh, J.H., Sedykh, A., Huang, R., Xia, M. and Tice, R.R. (2015) A data analysis pipeline accounting for artifacts in Tox21 quantitative high-throughput screening assays. J. Biomol. Screen, 20, 887-897.
16. Chen, S., Hsieh, J.H., Huang, R., Sakamuru, S., Hsin, L.Y, Xia, M., Shockley, K.R., Auerbach, S., Kanaya, N., Lu, H. et al. (2015) Cell-based high-throughput screening for aromatase inhibitors in the Tox21 10Klibrary. Toxicol. Sci., 147, 446-457.
17. Behl, M., Hsieh, J.H., Shafer, T.J., Mundy, W.R., Rice, J.R., Boyd, W.A., Freedman, J.H., Hunter, E.S. 3rd, Jarema, K.A., Padilla, S. et al. (2015) Use of alternative assays to identify and prioritize organophosphorus fame retardants for potential developmental and neurotoxicity. Neurotoxicol. Teratol., 52, 181-193.
18. Ganter, B., Snyder, R.D., Halbert, DN. and Lee, M.D. (2006) Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. Pharmacogenomics, 7, 1025-1044.
19. McMillian, M., Nie, A.Y, Parker, J.B., Leone, A., Bryant, S., Kemmerer, M., Herlich, J., Liu, Y, Yieh, L., Bittner, A. et al. (2004) A gene expression signature for oxidant stress/reactive metabolites in rat liver. Biochem. Pharmacol., 68, 2249-2261.
20. McMillian, M., Nie, A.Y, Parker, J.B., Leone, A., Kemmerer, M., Bryant, S., Herlich, J., Yieh, L., Bittner, A., Liu, X. et al. (2004) Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem. Pharmacol., 67, 2141-2165.
21. U.S. EPA. (2005) Guidelines for carcinogen risk assessment. Federal Register, 70, 177650-18717.
22. Crump, K. (2002) Critical issues in benchmark calculations from continuous data. Crit. Rev. Toxicol, 32, 133-153.
23. Crump, K.S. (1995) Calculation of benchmark doses from continuous data. Risk Anal, 15, 79-89.
24. Crump, K.S. (1984) A new method for determining allowable daily intakes. Fundam. Appl. Toxicol, 4, 854-871.
25. Attene-Ramos, M.S., Miller, N., Huang, R., Michael, S., Itkin, M., Kavlock, R.J., Austin, CP, Shinn, P, Simeonov, A., Tice, R.R. et al. (2013) The Tox21 robotic platform for the assessment of environmental chemicals-from vision to reality. Drug Discov. Today, 18, 716-723.